Drug Information

Drug General Information
Drug ID
D08OUL
Former ID
DNCL002849
Drug Name
EGT-0001474
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Phase 1 [522600]
Company
Theracos
Target and Pathway
Target(s) SLGT2 Target Info Modulator
Reactome Hexose transport
Na+-dependent glucose transporters
Inositol transporters
WikiPathways NRF2 pathway
Nuclear Receptors Meta-Pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
References
Ref 522600ClinicalTrials.gov (NCT00854113) Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers. U.S. National Institutes of Health.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.